The overall purpose of the Clinical Research Design, Epidemiology and Biostatistics (CRDEB) Core of the West Virginia Clinical and Translational Science Institute (WVCTSI) is to provide investigators throughout West Virginia (WV) with a centrally coordinated means of analytics support. This expertise will be delivered from a group of scientists that collectively bring a comprehensive set of skills ranging from general to highly specialized expertise in biostatistics and epidemiology. The goal is to enable investigators to rigorously address WVCTSI priority health areas that include: addiction & emerging epidemics (e.g., hepatitis C), cancer, cardiovascular disease, and chronic lung disease. We propose the following three specific aims: 1) effectively engage investigators throughout WV by providing traditional services in biostatistics and epidemiology, 2) implement cutting-edge tools and methods in biostatistics and epidemiology, with a particular focus on the needs of WV researchers, and 3) disseminate current and classical information in biostatistics and epidemiology. Statistics assistance will be provided to researchers via one-on-one consulting as well as walk-in clinics. Given the distance between institutions in WV, these consultations can occur either in-person or via phone, e-mail, Skype, etc. New methods for designing studies and analyzing data will focus on those most relevant to West Virginia and include adaptive response designs, predictive modeling, and clinical and population health epidemiology, making use of new data linkage capabilities. Methods focused on the conduct of ?real world? studies that can be conducted quickly and have a direct and immediate impact on the citizens of West Virginia will also be a major priority of this Core. To help achieve this goal, experts from throughout the United States will be invited to share their expertise with WV statisticians who can then apply these methods to locally collected data. To enhance the statistical knowledge base in WV, statisticians included in this project will offer seminars and workshops to investigators conducting research in WV. CRDEB faculty will also provide instruction in certificate and degree programs aimed at improving the research capacity in West Virginia. The ultimate goal of all of these activities is improving the health of all West Virginians.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54GM104942-04
Application #
9756382
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
4
Fiscal Year
2019
Total Cost
Indirect Cost
Name
West Virginia University
Department
Type
DUNS #
191510239
City
Morgantown
State
WV
Country
United States
Zip Code
26506
Ren, Xuefang; Engler-Chiurazzi, Elizabeth B; Russell, Ashley E et al. (2018) MiR-34a and stroke: Assessment of non-modifiable biological risk factors in cerebral ischemia. Neurochem Int :
Hodder, Sally; Squires, Kathleen; Kityo, Cissy et al. (2018) Brief Report: Efficacy and Safety of Switching to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide (E/C/F/TAF) in Virologically Suppressed Women. J Acquir Immune Defic Syndr 78:209-213
Paquette, Catherine E; Pollini, Robin A (2018) Injection drug use, HIV/HCV, and related services in nonurban areas of the United States: A systematic review. Drug Alcohol Depend 188:239-250
Kristjansson, Alfgeir L; Kogan, Steven M; Mann, Michael J et al. (2018) Does early exposure to caffeine promote smoking and alcohol use behavior? A prospective analysis of middle school students. Addiction :
Khouj, Yasser; Dawson, Jeremy; Coad, James et al. (2018) Hyperspectral Imaging and K-Means Classification for Histologic Evaluation of Ductal Carcinoma In Situ. Front Oncol 8:17
Tok, Fatih; Kocyigit-Kaymakcioglu, Bedia; Tabanca, Nurhayat et al. (2018) Synthesis and structure-activity relationships of carbohydrazides and 1,3,4-oxadiazole derivatives bearing an imidazolidine moiety against the yellow fever and dengue vector, Aedes aegypti. Pest Manag Sci 74:413-421
Rich, Katherine M; Bia, Joshua; Altice, Frederick L et al. (2018) Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV? Curr HIV/AIDS Rep 15:266-275
King, Dana E; Xiang, Jun; Pilkerton, Courtney S (2018) Multimorbidity Trends in United States Adults, 1988-2014. J Am Board Fam Med 31:503-513
Kapadia, Shashi N; Grant, Robert R; German, Susan B et al. (2018) HIV virologic response better with single-tablet once daily regimens compared to multiple-tablet daily regimens. SAGE Open Med 6:2050312118816919
Wiener, R Constance; Shen, Chan; Findley, Patricia et al. (2018) Dental Fluorosis over Time: A comparison of National Health and Nutrition Examination Survey data from 2001-2002 and 2011-2012. J Dent Hyg 92:23-29

Showing the most recent 10 out of 998 publications